List of Excipients in API oxycodone hydrochloride and ibuprofen
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing oxycodone hydrochloride and ibuprofen
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 | CALCIUM STEARATE |
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 | CELLULOSE, MICROCRYSTALLINE |
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 | CROSCARMELLOSE SODIUM |
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 | FERRIC OXIDE YELLOW |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for oxycodone hydrochloride and ibuprofen
Excipient focus: CALCIUM STEARATE
oxycodone hydrochloride and ibuprofen drug variants containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
oxycodone hydrochloride and ibuprofen drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
oxycodone hydrochloride and ibuprofen drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
oxycodone hydrochloride and ibuprofen drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
oxycodone hydrochloride and ibuprofen drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
oxycodone hydrochloride and ibuprofen drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
oxycodone hydrochloride and ibuprofen drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
oxycodone hydrochloride and ibuprofen drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
oxycodone hydrochloride and ibuprofen drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
oxycodone hydrochloride and ibuprofen drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
oxycodone hydrochloride and ibuprofen drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
oxycodone hydrochloride and ibuprofen drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
oxycodone hydrochloride and ibuprofen drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | oxycodone hydrochloride and ibuprofen | 0228-4029 |
| >Company | >Ingredient | >NDC |
oxycodone hydrochloride and ibuprofen drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch